Page last updated: 2024-10-27

gabexate and Alcoholic Pancreatitis

gabexate has been researched along with Alcoholic Pancreatitis in 2 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oka, A1
Amano, Y1
Uchida, Y1
Kagawa, K1
Tada, Y1
Kusunoki, R1
Fukuba, N1
Moriyama, I1
Yuki, T1
Ishihara, S1
Kinoshita, Y1
Ito, T1
Otsuki, M1
Itoi, T1
Shimosegawa, T1
Funakoshi, A1
Shiratori, K1
Naruse, S1
Kuroda, Y1

Other Studies

2 other studies available for gabexate and Alcoholic Pancreatitis

ArticleYear
Gastric intramural pseudocyst: a rare complication of pancreatic pseudocyst.
    Pancreas, 2013, Volume: 42, Issue:1

    Topics: Anti-Bacterial Agents; Endosonography; Gabexate; Gastric Fistula; Gastroscopy; Humans; Male; Middle

2013
Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan.
    Journal of gastroenterology, 2007, Volume: 42, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus; Esters; Female; Follow-Up Studies; Gabexate; Guan

2007